Pasithea Therapeutics (KTTA) Exchange Rate Effect (2021 - 2026)
Pasithea Therapeutics recorded quarterly Exchange Rate Effect of $28132.0 in Q1 2026, up 5949.89% quarter-over-quarter from $465.0 in Q4 2025.
Pasithea Therapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $28132.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect changed N/A year-over-year to $28132.0; the TTM figure through Mar 2026 stood at $69413.0 (changed N/A YoY), while the FY2025 annual figure was $18766.0, up 844.98% from the prior year.
- Exchange Rate Effect came in at $28132.0 for Q1 2026 at Pasithea Therapeutics, up from $465.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $139421.0 in Q4 2022 to a low of -$82515.0 in Q3 2022.
- A 5-year average of $2977.1 and a median of -$620.0 in 2024 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 2150.61% in 2022 and fell as far as 5590.69% in 2022.
- Pasithea Therapeutics' Exchange Rate Effect stood at $139421.0 in 2022, then sank by 97.8% to $3065.0 in 2023, then jumped by 818.3% to $28146.0 in 2024, then sank by 98.35% to $465.0 in 2025, then surged by 5949.89% to $28132.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $28132.0, $465.0, and $12670.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | 28,132.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,132.00 |
| Mar 31, 2026 | 28,132.00 |
| Dec 31, 2025 | 465.00 |
| Dec 31, 2025 | 465.00 |
| Sep 30, 2025 | 12,670.00 |
| Sep 30, 2025 | 12,670.00 |
| Dec 31, 2024 | 28,146.00 |
| Dec 31, 2024 | 28,146.00 |
| Sep 30, 2024 | -27,133.00 |
| Sep 30, 2024 | -27,133.00 |
| Jun 30, 2024 | -2,912.00 |
| Jun 30, 2024 | -2,912.00 |
| Mar 31, 2024 | -620.00 |
| Mar 31, 2024 | -620.00 |
| Dec 31, 2023 | 3,065.00 |
| Dec 31, 2023 | 3,065.00 |
| Sep 30, 2023 | -4,256.00 |
| Sep 30, 2023 | -4,256.00 |
| Jun 30, 2023 | -317.00 |
| Jun 30, 2023 | -317.00 |
| Mar 31, 2023 | -2,483.00 |
| Mar 31, 2023 | -2,483.00 |
| Dec 31, 2022 | 139,421.00 |
| Dec 31, 2022 | 139,421.00 |
| Sep 30, 2022 | -82,515.00 |
| Sep 30, 2022 | -82,515.00 |
| Jun 30, 2022 | -42,493.00 |
| Jun 30, 2022 | -42,493.00 |
| Mar 31, 2022 | -4,513.00 |
| Mar 31, 2022 | -4,513.00 |
| Dec 31, 2021 | -6,799.00 |
| Dec 31, 2021 | -6,799.00 |
| Sep 30, 2021 | -1,450.00 |
| Sep 30, 2021 | -1,450.00 |